Corriente Advisors, LLC

SEC CIK: 0001406718
Latest filing: Feb 14, 2024

SEC filings (opens in a new tab)

DMAC holding history

DiaMedica Therapeutics Inc. in every 13F filed by Corriente Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DMAC overview All 13F holders of DMAC Full Q4 2023 holdings

Shares (Q3 2021): 0; Sold out in Q3 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of DMAC by Corriente Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2021	0	$0	0.0%	−203,641−100.0%	Sold out	Holders
Q2 2021	203,641	$906.0K	0.5%	−666,587−76.6%	Reduced	Holders
Q1 2021	870,228	$7.96M	2.9%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.